Keep Your Eyes on This Stock: Zimmer Biomet Holdings (ZBH)

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) spotted trading -21.47% off 52-week high price. On the other end, the stock has been noted 8.94% away from the low price over the last 52-weeks. The stock changed -0.17% to recent value of $105.66. The stock transacted 961758 shares during most recent day however it has an average volume of 1327.59K shares. The company has 203.7M of outstanding shares and 203.56M shares were floated in the market.  

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) announced that it will participate in the 8th Annual SVB Leerink Global Healthcare Conference at the Lotte New York Palace in New York, New York. Cole Lannum, Senior Vice President of Investor Relations, will present for the Company on February 27, 2019 at 11:30 a.m. Eastern Time.

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.

 Its earnings per share (EPS) expected to touch remained 75.90% for this year while earning per share for the next 5-years is expected to reach at 3.88%. ZBH has a gross margin of 70.90% and an operating margin of 9.90% while its profit margin remained 22.10% for the last 12 months. 

 According to the most recent quarter its current ratio was 1.9 that represents company’s ability to meet its current financial obligations. The price moved ahead of 1.62% from the mean of 20 days, -1.97% from mean of 50 days SMA and performed -8.94% from mean of 200 days price. Company’s performance for the week was 1.67%, 3.88% for month and YTD performance remained 1.87%.

Leave a Reply

Your email address will not be published. Required fields are marked *